Rationalizing 5000-fold differences in receptor-binding rate constants of four cytokines.

The four cytokines erythropoietin (EPO), interleukin-4 (IL4), human growth hormone (hGH), and prolactin (PRL) all form four-helix bundles and bind to type I cytokine receptors. However, their receptor-binding rate constants span a 5000-fold range. Here, we quantitatively rationalize these vast differences in rate constants by our transient-complex theory for protein-protein association. In the transient complex, the two proteins have near-native separation and relative orientation, but have yet to form the short-range specific interactions of the native complex. The theory predicts the association rate constant as k(a)=k(a0)exp(-ΔG(el)(∗)/k(B)T) where k(a0) is the basal rate constant for reaching the transient complex by random diffusion, and the Boltzmann factor captures the rate enhancement due to electrostatic attraction. We found that the vast differences in receptor-binding rate constants of the four cytokines arise mostly from the differences in charge complementarity among the four cytokine-receptor complexes. The basal rate constants (k(a0)) of EPO, IL4, hGH, and PRL were similar (5.2 × 10(5) M(-1)s(-1), 2.4 × 10(5) M(-1)s(-1), 1.7 × 10(5) M(-1)s(-1), and 1.7 × 10(5) M(-1)s(-1), respectively). However, the average electrostatic free energies (ΔG(e1)(∗)) were very different (-4.2 kcal/mol, -2.4 kcal/mol, -0.1 kcal/mol, and -0.5 kcal/mol, respectively, at ionic strength=160 mM). The receptor-binding rate constants predicted without adjusting any parameters, 6.2 × 10(8) M(-1)s(-1), 1.3 × 10(7) M(-1)s(-1), 2.0 × 10(5) M(-1)s(-1), and 7.6 × 10(4) M(-1)s(-1), respectively, for EPO, IL4, hGH, and PRL agree well with experimental results. We uncover that these diverse rate constants are anticorrelated with the circulation concentrations of the cytokines, with the resulting cytokine-receptor binding rates very close to the limits set by the half-lives of the receptors, suggesting that these binding rates are functionally relevant and perhaps evolutionarily tuned. Our calculations also reproduced well-observed effects of mutations and ionic strength on the rate constants and produced a set of mutations on the complex of hGH with its receptor that putatively enhances the rate constant by nearly 100-fold through increasing charge complementarity. To quantify charge complementarity, we propose a simple index based on the charge distribution within the binding interface, which shows good correlation with ΔG(e1)(∗). Together these results suggest that protein charges can be manipulated to tune k(a) and control biological function.

[1]  T. Clackson,et al.  A hot spot of binding energy in a hormone-receptor interface , 1995, Science.

[2]  J. García-Ruíz,et al.  Prolactin increases cytosolic free calcium concentration in hepatocytes of lactating rats. , 1991, Endocrinology.

[3]  Huan‐Xiang Zhou,et al.  Electrostatic rate enhancement and transient complex of protein–protein association , 2008, Proteins.

[4]  A. Sali,et al.  Modeling of loops in protein structures , 2000, Protein science : a publication of the Protein Society.

[5]  S. Masuda,et al.  The role of carbohydrate in recombinant human erythropoietin. , 1990, European journal of biochemistry.

[6]  X. Z. Zhou Calculation of translational friction and intrinsic viscosity. II. Application to globular proteins. , 1995, Biophysical journal.

[7]  T. Clackson,et al.  Structural and functional analysis of the 1:1 growth hormone:receptor complex reveals the molecular basis for receptor affinity. , 1998, Journal of molecular biology.

[8]  R C Wade,et al.  Protein-protein association: investigation of factors influencing association rates by brownian dynamics simulations. , 2001, Journal of molecular biology.

[9]  Huan‐Xiang Zhou,et al.  Energy landscape and transition state of protein-protein association. , 2006, Biophysical journal.

[10]  Huan-Xiang Zhou,et al.  Prediction of salt and mutational effects on the association rate of U1A protein and U1 small nuclear RNA stem/loop II. , 2008, The journal of physical chemistry. B.

[11]  Gideon Schreiber,et al.  Fundamental Aspects of Protein—Protein Association Kinetics , 2009 .

[12]  A. Elcock,et al.  Absolute protein-protein association rate constants from flexible, coarse-grained Brownian dynamics simulations: the role of intermolecular hydrodynamic interactions in barnase-barstar association. , 2010, Biophysical journal.

[13]  A. McCoy,et al.  Electrostatic complementarity at protein/protein interfaces. , 1997, Journal of molecular biology.

[14]  Huan-Xiang Zhou,et al.  Rate theories for biologists , 2010, Quarterly Reviews of Biophysics.

[15]  Huan‐Xiang Zhou,et al.  Prediction of protein-protein association rates from a transition-state theory. , 2007, Structure.

[16]  Anthony A Kossiakoff,et al.  The high- and low-affinity receptor binding sites of growth hormone are allosterically coupled. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  I. Wilson,et al.  Shared and Unique Determinants of the Erythropoietin (EPO) Receptor Are Important for Binding EPO and EPO Mimetic Peptide* , 1999, The Journal of Biological Chemistry.

[18]  W. Sebald,et al.  Design of human interleukin-4 antagonists inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T-cells and B-cells with high efficiency. , 1994, European journal of biochemistry.

[19]  Huan-Xiang Zhou,et al.  Dissection of the high rate constant for the binding of a ribotoxin to the ribosome , 2009, Proceedings of the National Academy of Sciences.

[20]  J. M. Beals,et al.  Glycosylation of erythropoietin affects receptor binding kinetics: role of electrostatic interactions. , 2002, Biochemistry.

[21]  M. Dwyer,et al.  Dissecting the binding energy epitope of a high-affinity variant of human growth hormone: cooperative and additive effects from combining mutations from independently selected phage display mutagenesis libraries. , 2004, Biochemistry.

[22]  J. Wells,et al.  Structural and mutational analysis of affinity-inert contact residues at the growth hormone-receptor interface. , 1996, Biochemistry.

[23]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .

[24]  Robert M. Stroud,et al.  Efficiency of signalling through cytokine receptors depends critically on receptor orientation , 1998, Nature.

[25]  D. Goeddel,et al.  Rational design of potent antagonists to the human growth hormone receptor. , 1992, Science.

[26]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules J. Am. Chem. Soc. 1995, 117, 5179−5197 , 1996 .

[27]  G Schreiber,et al.  Electrostatically optimized Ras-binding Ral guanine dissociation stimulator mutants increase the rate of association by stabilizing the encounter complex. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Y. Wang,et al.  A mixed-charge pair in human interleukin 4 dominates high-affinity interaction with the receptor α chain , 1997 .

[29]  J W Fisher,et al.  Glycosylation at specific sites of erythropoietin is essential for biosynthesis, secretion, and biological function. , 1988, The Journal of biological chemistry.

[30]  S. Wenzel,et al.  Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies , 2007, The Lancet.

[31]  P. Johnston,et al.  EPO's Alter Ego: Erythropoietin Has Multiple Actions , 2002, Stem cells.

[32]  S. Frank Receptor dimerization in GH and erythropoietin action--it takes two to tango, but how? , 2002, Endocrinology.

[33]  Y. Wang,et al.  The interleukin-4 site-2 epitope determining binding of the common receptor gamma chain. , 1998, European Journal of Biochemistry.

[34]  J. Nerup,et al.  Letter: Yersinia enterocolitica infection and thyroid disorders. , 1974, Lancet.

[35]  A. Wickrema,et al.  Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells. , 1992, Blood.

[36]  R. Baxter Measurement of growth hormone and prolactin receptor turnover in rat liver. , 1985, Endocrinology.

[37]  J A McCammon,et al.  Computer simulation of protein-protein association kinetics: acetylcholinesterase-fasciculin. , 1999, Journal of molecular biology.

[38]  P. Reinemer,et al.  Crystal Structure of the Interleukin-4/Receptor α Chain Complex Reveals a Mosaic Binding Interface , 1999, Cell.

[39]  Gideon Schreiber,et al.  Rational design of faster associating and tighter binding protein complexes , 2000, Nature Structural Biology.

[40]  S. Frank Minireview: Receptor Dimerization in GH and Erythropoietin Action-It Takes Two to Tango, But How? , 2002, Endocrinology.

[41]  R C Wade,et al.  Simulation of the diffusional association of barnase and barstar. , 1997, Biophysical journal.

[42]  R. Puri,et al.  Transcriptional up-regulation of interleukin 4 receptors by human immunodeficiency virus type 1 tat gene. , 1996, AIDS research and human retroviruses.

[43]  S. Holgate,et al.  IL-4 Receptor α Is an Important Modulator of IL-4 and IL-13 Receptor Binding: Implications for the Development of Therapeutic Targets1 , 2006, The Journal of Immunology.

[44]  T. Arakawa,et al.  Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction. , 1996, Biochemistry.

[45]  M. Ultsch,et al.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.

[46]  P. J. Randle,et al.  Immunoassay of growth hormone in human serum. , 1961, Proceedings of the Royal Society of Medicine.

[47]  Patrick England,et al.  Structural characterization of the stem-stem dimerization interface between prolactin receptor chains complexed with the natural hormone. , 2010, Journal of molecular biology.

[48]  W. Sebald,et al.  The interleukin‐4 site‐2 epitope determining binding of the common receptor γ chain , 1998 .

[49]  A. Bondi van der Waals Volumes and Radii , 1964 .

[50]  Nathan A. Baker,et al.  Electrostatics of nanosystems: Application to microtubules and the ribosome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[51]  P. Reinemer,et al.  INTERLEUKIN-4 / RECEPTOR ALPHA CHAIN COMPLEX , 2000 .